Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)
Authors
Keywords
-
Journal
DIABETIC MEDICINE
Volume 30, Issue 6, Pages 702-709
Publisher
Wiley
Online
2013-02-24
DOI
10.1111/dme.12166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble RAGE and malondialdehyde in type 1 diabetes patients without chronic complications during the course of the disease
- (2012) Janice S Reis et al. Diabetes & Vascular Disease Research
- Relationship of Soluble RAGE and RAGE Ligands HMGB1 and EN-RAGE to Endothelial Dysfunction in Type 1 and Type 2 Diabetes Mellitus
- (2012) J. Škrha Jr et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)
- (2011) Barry I. Hudson et al. ATHEROSCLEROSIS
- RAGE biology, atherosclerosis and diabetes
- (2011) Drazenka Pongrac Barlovic et al. CLINICAL SCIENCE
- Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
- (2011) H. M. Colhoun et al. DIABETES
- Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
- (2011) M. C. Thomas et al. DIABETOLOGIA
- Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus
- (2011) A. Dettoraki et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
- (2010) Johanna W.M. Nin et al. DIABETES
- Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes
- (2009) H.L. Tam et al. ATHEROSCLEROSIS
- RAGE: a novel biological and genetic marker for vascular disease
- (2009) Anastasia Z. Kalea et al. CLINICAL SCIENCE
- Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms
- (2009) N. Grossin et al. DIABETES & METABOLISM
- Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications
- (2009) Jason B Lindsey et al. Diabetes & Vascular Disease Research
- Soluble forms of RAGE in internal medicine
- (2009) Natale Vazzana et al. Internal and Emergency Medicine
- Calcium-regulated intramembrane proteolysis of the RAGE receptor
- (2008) Arnaud Galichet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients
- (2008) Naoto Katakami et al. Diabetes & Vascular Disease Research
- A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
- (2008) Angela Raucci et al. FASEB JOURNAL
- Identification, classification, and expression of RAGE gene splice variants
- (2007) Barry I. Hudson et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now